Komori
Astellas Pharma (4503) · InitiativeAchieved

Termination of the Japanese Promotion and Exclusive Distribution Agreement for Protopic

First written in FY2018-Q2. 1 of 1 entries say "Achieved", first in FY2018-Q2. Latest entry: FY2018-Q2.

1entries
1years
0from disclosures
Share on X
How it moved
Same theme, other companies
Termination of the Japan Promotion and Exclusive Sales Agreement for Protopic with MaruhoA theme 1 companies write about · 1 as a headwind · 0 as a tailwind

No other company in this theme has enough history to compare yet.

Full recordFilings, disclosures and news, newest first
  1. FY2018-Q2AchievedAnnual report

    「当第２四半期連結会計期間において、以下の取引契約を終了しました。 当社の「プロトピック軟膏」の日本におけるプロモーション委託及び独占的販売権許諾契約 2010年７月～2017年９月」

    プロトピック軟膏について、マルホ株式会社との日本におけるプロモーション委託及び独占的販売権許諾契約を2017年9月に終了した。
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
Astellas Pharma's next results are scheduled for 2026-11-04. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.